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1.1 Paramagnetic Nuclear Magnetic Resonance Spectroscopy
Nuclear magnetic resonance (NMR) spectroscopy is ideally suited for the elucidation of structure, dynamics and interactions of
biomacromolecules in solution.1 The development of homo- and heteronuclear experiments in order to establish through-bond2–5
and through-space correlations6,7 allow for the complete assignment of the protein by experiments linking the amide proton with
the backbone and side chain spins from the obtained through-bond correlations. The three-dimensional structure of the protein is
then computed using the structural restraints obtained (Fig. 1).6,7,10,11 The possibility to tune and adjust the sample conditions, e.g.
buffer composition, salt concentration, temperature, additives and pH, allows for realistic experiments that can be adjusted to
specific physiological conditions.1 Furthermore, the dynamics of the protein of interest can be investigated by analysis of relaxation
times and heteronuclear Overhauser effects (hetNOEs).12,13 Besides the convenient application of advanced NMR techniques to
proteins, assignment techniques and further experiments were developed for nucleic acids in order to elucidate their structure,
dynamics and protein–nucleic acid complexes.14–17 However, the distance limitation of the exploited nuclear Overhauser effect
(NOE) of 5–8 Å for structure calculations and unspecific chemical shift perturbation (CSP) experiments, used for the monitoring of
interactions of biomacromolecules and ligand-binding, render more advanced methods that yield structural restraints over larger
distances highly desirable. Paramagnetic NMR can contribute in this regard by providing long-range, through-space interactions in
order to obtain distance and orientational restraints of biomacromolecules and their complexes with other biomacromolecules and
ligand molecules.18
An impressive and early study described the quantitative determination of the conformations of mononucleotides in solution
using lanthanoid induced shifts,19 and in the following, Bertini, Banci, Luchinat et al. exploited the paramagnetism of lanthanoids
by substitution of diamagnetic metal ions in metalloproteins and demonstrated thereby thoroughly the application and use of
paramagnetic NMR in structural biology.20–23 In order to enable the introduction of lanthanoid centers into proteins without native
metal site in order to take advantage of the paramagnetism-based structural restraints, lanthanoid binding peptides (LBPs) that
imitate the zinc finger and EF hand motif of native metalloproteins were developed24–27 and can be added to the N- or C-terminus
of the protein of interest. In order to provide more rigid chelators and attach an LCT at any possible position within the scaffold of
the biomacromolecule, a large variety of double- and single-armed lanthanoid chelating tags (LCTs) has been developed.28–37 LCTs
have since then found widespread applications in structural biology and biomolecular NMR, e.g. structural characterization ofComprehensive Coordination Chemistry III https://doi.org/10.1016/B978-0-12-409547-2.14848-6 1
Fig. 1 Solution NMR Structure of hVDAC-1 in LDAO Detergent Micelles refined using NMR restraints. Backbone representation of the 10 conformers with lowest
violation of dihedral angles and NOE restraints (A, N-terminus: green, loops: light blue, b-strands: blue). Refined conformer closest to the mean (B, top view). NOE
contacts between the N-terminal helices and the wall of the membrane protein (C, NOE contacts: black, N-terminus: green, loops: light blue, b-strands: blue).
Overlay of the refined solution NMR structure of hVDAC-1 with the crystal structure of mVDAC-1 (D, PDB 3EMN8).9 NMR Studies of Structure and Function of
Biological Macromolecules (Nobel Lecture). Wüthrich, K.; Angew. Chem. Int. Ed. Engl. 2003, 42, 3340–3363.
2 Application of Paramagnetic LCTs in NMR Spectroscopyantibiotic drug targets (Fig. 2),39 localization of ligands within proteins,40,41 observation of long-range RNA structural information
using a paramagnetically tagged reporter protein,42 enhancement of signal dispersion in studies of intrinsically disordered
proteins,43 structural analysis of biologically highly relevant, large complexes of biomacromolecules44 and characterization of the
interactions between glycans and proteins.45
The introduction of paramagnetic centers in biomacromolecules by either direct complexation by metalloproteins, modification
of the protein construct with an LBP or attachment of a small-molecule chelator with appropriate linker moiety leads to sizeable
effects visible in NMR experiments that were thoroughly and critically reviewed in multiple reviews.18,46–64 The most important
effects associated with induced anisotropy caused by paramagnetic centers comprise pseudocontact shifts (PCS),28,30,33,34,36,37,65–72
residual dipolar couplings (RDC)73–77 and paramagnetic relaxation enhancement (PRE).78–84 PCSs and RDCs are exemplified in
Fig. 3 by depicting a concrete example of an in-cell NMR study, that delivered de-novo derived protein structures from 2D NMR
experiments. Besides the most important paramagnetic effects as PCS, RDC and PRE, also contact shifts (CS),85–88 residual
anisotropic chemical shifts (RACS),89,90 dipolar shift anisotropy (DSA) as well as cross-correlation between DSA and dipolar
relaxation (DSA/DD)91 are associated with the incorporation of a paramagnetic center in a target of interest.
Most importantly, the shifts caused by through-space PCS effects provide angular and distance information about the nucleus.
Upon application of PCS NMR on proteins, the sequential assignment of backbone amides can be combined with PCS shift data
and, therefore, be used in order to obtain structural restraints for each backbone N and H spin. Due to their distance dependence ofFig. 2 Caged lanthanoid NMR probe (CLaNP-5)28 attached to a double cysteine mutant of MurD for monitoring of conformational changes. Induced isosurfaces of
the Yb3+-loaded LCT when ligated to domains 1 and 2 (PCS +/− 0.5 ppm, blue: positive, red: negative, PDB: 3UAG,38 left). Monitoring of the open and closed
conformation of domain 3 using PCS restraints (right).39 Ligand-driven conformational changes of MurD visualized by paramagnetic NMR. Saio, T.; Ogura, K.;
Kumeta, H.; Kobashigawa, Y.; Shimizu, K.; Yokochi, M.; Kodama, K.; Yamaguchi, H.; Tsujishita, H.; Inagaki, F. Sci. Rep. 2015, 5, 16685. Nature Publishing Group.
Fig. 3 PCS induced by a Tm-DOTA-M7Py in comparison with its diamagnetic reference Lu-DOTA-M7Py observed on a GB1 E19C construct in 1H-15N
heteronuclear single quantum coherence (HSQC) experiments (PCS +/− 2.0 ppm, blue: positive, red: negative, left). Partial alignment of the labeled protein to the
external magnetic field B0 leading to RDCs observed in
1H-15N HSQC IPAP experiments.33 Reproduced with permission from Müntener, T.; Häussinger, D.;
Selenko, P.; Theillet, F.-X. J. Phys. Chem. Lett. 2016, 7, 2821–2825. Copyright 2016 American Chemical Society.
Application of Paramagnetic LCTs in NMR Spectroscopy 3R−3, PCSs can yield structural restraints over distances of more than 200 Å in favorable cases.18 In contrast to the through space
nature of PCSs, CSs are through-bond effects and only transferred over a few chemical bonds and are, therefore, less interesting for
the analysis of biomacromolecules. However, CSs can give valuable insights into ligand structure and conformation, since the
observed shifts are dependent on the structure and bonding interactions.92,93
RDCs are especially well suited for structural analysis of large biomacromolecules, since the effect is independent of the distance
between the paramagnetic center and the measured nucleus and yields the orientation of the NdH bond vectors in space as
structural restraints. RDCs can either be induced by partial alignment of the biomacromolecules by incorporation of an paramag-
netic lanthanoid ion with anisotropic electron distribution or by application of an alignment medium as bacteriophages,
acrylamide gels or bicelles.73,77,94 The RDCs induced by incorporation of paramagnetic centers can be diminished due to internal
flexibility of the biomacromolecule, however, this effect can then be further exploited to determine, for example, the stiffness of an
a-helix and to draw conclusions about the biological significance of the gained insight.77 Combination of LCT-induced PCSs and
RDCs was used to determine backbone structures of biomacromolecules inside intact eukaryotic cells, as a unique property of
covalently bound high affinity LCTs is their compatibility with in-cellulo experiments.33,69,95
PRE is, in a first approximation, an isotropic effect and thus yields only distance and no angular information. Furthermore, the
magnitude of the effect decreases with R−6 with respect to the distance between the observed spin and the paramagnetic center.
However, PREs are not very susceptible to motional averaging, are convenient to induce by commercially available spin labels and
are more straightforward to analyze than PCSs and RDCs. Nonetheless, since PCSs provide both distance and angular information,
exhibit a distance dependence of R−3 and can be observed on any NMR active nuclei, e.g. 1H, 13C, 15N, 19F, or 31P by one- or
multidimensional NMR experiments, PCSs are perfectly well suited for the localization of ligands within biomacromolecules.
The PCS is a dipolar, through-space effect arising from the dipolar interaction between the nuclear spin and, in the case of LCTs,
the orbital momentum of the unpaired f-electrons of the paramagnetic lanthanoid center that manifests in NMR experiments by a
shift contribution to the NMR resonance of the detected nucleus, depending on the positioning of the nuclear spin with respect to
the metal center.96 Since the distance between the spin and the paramagnetic metal center is much larger than the ionic radius of the
metal center, the point-dipole approximation can be applied that depicts the magnetic dipole moment as located in a single point.62
The PCS can then be translated into structural restraints by fitting of the experimental data to a known or calculated structure using
software packages like Numbat97 or Paramagpy.98 Programs capable of PCS analysis minimize the difference between observed and
back-calculated PCS in an iterative fashion until the convergence is achieved. The resulting axial and rhombic parameters of the
observed anisotropy tensors should be reported in the unique tensor representation (UTR) using the zyz’ convention, as only this
representation allows for direct comparison with tensors from other LCTs.62 In order to visualize the anisotropy parameters induced
by the lanthanoid within the biomacromolecule in a suitable fashion, isosurfaces for given ppm values are displayed graphically
(Fig. 4).
Thereby, the strength of the shifts in different regions of a biomacromolecule can be directly and visually inspected, e.g. with the
program PyMOL. While red parts by definition indicate regions with negative shifts, blue parts constitute regions with positively
shifted NMR signals. By the use of PCS analysis, each N and H nucleus can be localized in the three-dimensional space, and
therefore valuable structural information can be gained about the structure of the protein of interest. More specifically, a de-novo
derived structure can be obtained by starting the refinement process from an in silico structure, e.g. by use of the Rosetta database.
Structures from X-ray crystallography can be refined in solution by PCS and crucial differences between the solution- and solid-state
structures, e.g. a different ordering or conformation of more flexible regions within a protein or the alignment of different protein
domains, can immediately be detected due to poor fits of the data set obtained via paramagnetic NMR spectroscopy.39,99 For nucleic
acids, the methodology can be applied e.g. with total correlation spectroscopy (TOCSY) or nuclear Overhauser effect spectroscopy
(NOESY) spectra.72 The PCS can be calculated by use of the following equation that can be displayed both in polar or Cartesian
coordinates96:
Fig. 4 Isosurfaces induced by the attachment of Ln-P4T-DOTA complexes (Dy3+: left, Tm3+: right) and their relative orientation to ubiquitin S57C (PCS isosurfaces:
1.5 ppm (outer layer), 4.0 ppm (inner layer)).37 Reproduced by permission of The Royal Society of Chemistry from Joss, D.; Häussinger, D. Chem. Commun. 2019,
55, 10543–10546.
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For the complete description of the anisotropic part of the magnetic susceptibility that is induced by the lanthanoid ion
incorporated in or attached to a biomacromolecule of interest, in total eight parameters are required: axial and rhombic component
of the magnetic susceptibility tensor (Dwax and Dwrh), the coordinates of the paramagnetic center (x, y, z) and the Euler angles
describing the orientation with regard to the coordinate frame of the protein (a, b, g). The anisotropy parameters DXax and DXrh
describe the directional asymmetry of a tensor using the following definitions96:




Rhombicity Dwrh ¼ wxx − wyy (4)
As discussed, software packages, e.g. Numbat97 or Paramagpy98 are used to derive the anisotropy parameters from the experimental
data by minimizing the difference between the experimental and back-calculated PCS for a given structure (Fig. 5).
Alternative approaches use a given set of PCS in combination with a known or partially known structure for assignment of
methyl groups100,101 or the localization of ligand atoms40,41,102 within a biomacromolecule of interest.
The aim of this case study is to provide the reader with basic knowledge about LCTs and the application of LCTs for the
localization of ligands within biomacromolecules using PCS analysis with a particular focus on the localization of fluorinated
ligands within human carbonic anhydrase II (hCA II) using PCS as long-range restraints with a high accuracy over long metal-
fluorine distances.Fig. 5 View on a part of the interface of the novel software package Paramagpy for PCS fitting. Correlation plot of experimental and calculated PCS (left) and
isosurfaces of Er3+ incorporated in calbindin D9k (PyMOL, right).98 Paramagpy: Software for Fitting Magnetic Susceptibility Tensors Using Paramagnetic Effects
Measured in NMR Spectra. Orton, H. W.; Huber, T.; Otting, G. Magn. Reson. Discuss. 2019, 1–18. Copernicus publications
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2.1 Introduction and Overview
In order to exploit the paramagnetic effects induced by lanthanoids in biomacromolecules, the most important and basic
consideration is the incorporation of the lanthanoid center into the biological target of interest. As demonstrated by Bertini et al.,
the most simple and convenient starting point is a protein that possesses a native metal binding site, e.g. calbindin D9k. Due to the
similar oxophilicity and ionic radius of the members of the lanthanoid series when compared with Ca2+ ions,103 paramagnetic
lanthanoid ions can often be incorporated in calcium binding sites. Given that the protein exhibits only one calcium binding site or
only one calcium binding site that is amenable for substitution with a lanthanoid ion, the induced paramagnetic effects can then be
used as structural restraints for the characterization of the protein scaffold.104 Furthermore, the fixed protein coordination site can
also be used for a study of the induced anisotropy parameters by the full series of lanthanoids.47,105 However, it is important to note
that the displayed anisotropy of lanthanoid centers can depend strongly on the type of donor atoms and the coordination
polyhedron of the lanthanoid complex.106–110 While the direct substitution of calcium by lanthanoid ions is highly interesting
for any protein containing a suitable metal binding site, the incorporation of lanthanoid ions into other proteins has to rely on
external tags that are fused to the protein during expression or by attachment to specific residues on the surface of the protein.
LBPs mimic the native metal binding site of metalloproteins and can conveniently be inserted into the sequence or fused to the
termini of the protein.25–27,111,112 In order to enhance the rigidity of the lanthanoid binding site delivered by the LBP with respect to
the protein scaffold, two-point anchored LBPs, i.e. an LBP linked to the protein through one peptide fusion and one disulfide bond,
present an appealing improvement.27 Although this modification always leads to complete ligation yields for the attachment of the
tag to the protein, significant drawbacks are associated with LBPs, i.e. the incorporation of the tag is mostly performed at the termini
of the sequence since otherwise a significant distortion of the protein scaffold is possible, the additional residues lead to more
crowded protein NMR spectra and the rigidity as well as properties of the chelator cannot be that specifically tuned as e.g. with
chelators based on ethylenediaminetetraacetic acid (EDTA) or 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)
scaffolds. To avoid these drawbacks, LBPs that circumvent this severe restriction by anchoring the LBP via cysteine residues to the
protein were proposed.113,114
In order to enable the tuning of the induced paramagnetic effects and the incorporation of different linker moieties and ligand
donor atoms, the attachment of common metal chelators as EDTA,115,116 diethylenetriaminepentaacetic acid (DTPA),117 or
DOTA28,29 and their site-specific attachment to single cysteine residues proved to be highly successful (Fig. 6). Cysteine residues
are specifically well-suited to serve as attachment point of an LCT, since they can be introduced on the surface of the protein by
mutation by replacing a serine for a cysteine residue without distortion of the local structure. Most importantly, the nucleophilicity
of cysteines, due to the significant fraction of deprotonated cysteine thiols around the physiological pH, renders them very attractive
for ligation to an LCT with an electrophilic attachment point. Furthermore, cysteines display a low abundance of only 1.4% in
protein sequences (average of proteins contained in the UniProtKB/Swiss-Prot data bank).118
Synthetic LCTs can be designed in virtually any substitution and donor atom pattern18 and allow a high variety of thiol-reactive
moieties to be incorporated, i.e. activated mixed disulfides,29,34,36 activators with pyridinesulfone leaving groups,33,69,119 pyridi-
nethiazole moieties,35,37 bioorthogonal activators,67,120 or two-point anchoring disulfides that strongly restrict the flexibility of the
LCT on the surface of the protein.28,121–124
However, a serine to cysteine mutation can be problematic for proteins that show instability upon displaying cysteine residues
on their surface or for proteins that display multiple cysteine residues, which are required in order to fulfill their biological function,
on their surface. In the future, bio-orthogonal conjugation to artificial amino acids that can be incorporated into the genetic code,
are expected to play a key role in the incorporation of LCTs into proteins and paramagnetic NMR spectroscopy of
biomacromolecules.2.2 EDTA-Based Lanthanoid Chelating Tags
In order to evolve the methodology of inducing paramagnetic effects by lanthanoid-loaded peptide motifs further to a more
versatile chelator that is independent of the process of protein expression, suitable synthetic chelators were required and auspiciousFig. 6 Scaffolds of chelators used for the synthesis of LCTs.
6 Application of Paramagnetic LCTs in NMR Spectroscopycandidates were EDTA and DTPA scaffolds. The development of LCTs started therefore with the synthesis of EDTA-derived LCTs that
were then conjugated to a cysteine residue of a protein in order to observe structural restraints on covalently tagged proteins.
The development of an EDTA-derived LCT and its application for paramagnetic protein NMR was first reported by Dvoretsky
et al.125 The Yb3+-loaded chelator equipped with a pyridine-2-thiol activated linker moiety was attached to barnase H102C and the
obtained structural restraints, i.e. PCS and RDC, were fitted to the X-ray structure of wild-type barnase.
Two years later, an enantiomerically pure EDTA-based LCT with a disulfide linker was proposed by Ikegami et al.115 Upon
conjugation of the LCT to trigger factor, a molecular chaperone associated with the ribosome, RDCs of up to 8 Hz were observed at
800 MHz proton frequency. However, upon equipping the EDTA-based LCT with a linker, and coordination of the metal that leads
to a fixed geometry, a nitrogen atom within the chelator becomes a stereogenic center and two diastereomeric species are formed.
The two diastereomeric species lead, when attached to the protein of interest, to a second set of peaks in 1H-15N HSQC spectra.
A significant improvement was then achieved by Leonov et al., who attached the linker of the LCT to the carbon backbone of the
EDTA ligand instead of the nitrogen atom.126 Thereby, each of the two nitrogen atoms is substituted by two identical groups and
despite the fact, that still two enantiomers of the LCT can be formed, in favorable cases only one set of signals was observed in
1H-15N HSQC experiments.
In 2006, two novel EDTA chelators were reported by Haberz et al. that lead to linearly independent anisotropy parameters when
compared to previously synthesized EDTA-tags.127 Interestingly, the LCTs were applied for the solution structure refinement of
trigger factor and the authors demonstrated that the affinity of the newly synthesized LCTs for lanthanoids is higher than the one of
the native metal binding site in calmodulin. By the design and synthesis of EDTA-derived LCTs, it was successfully demonstrated
that the methodology of the LBPs can be successfully transferred to the use of synthetic metal chelators. The important advantage of
the newly synthesized LCTs is that they can be attached at multiple sites within a protein. However, the observed anisotropy
parameters were only of modest size and for some of the EDTA-based tags peak doubling was observed that severely complicates
assignment of the spectra. Therefore, other metal chelators were tested in order to serve as scaffolds for LCTs, as e.g. diethylene-
triaminetetraacetic acid (DTTA) and DTPA ligands.2.3 DTTA- and DTPA-Based Lanthanoid Chelating Tags
In order to improve the initially developed EDTA tags, DTTA- and DTPA-derived LCTs were synthesized and applied in paramag-
netic NMR of biomacromolecules.
As a first example, Prudêncio et al. proposed in 2004 a DTPA-based LCT with two linker moieties that was termed CLaNP and is
attached to suitable double-cysteine mutants of the protein of interest.117 However, the authors detected up to five signals per
residue in 1H-15N HSQC spectra. In Ln-DTPA-bisamide complexes, in theory up to eight different stereoisomers can be formed,
although it is likely that the occurrence of some species is promoted by interaction of the chelator with the surface of the
protein.62,128 Although the occurrence of multiple species was rather discouraging, observable PCSs were detected even on nuclei
further away than 40 Å, a result that confirmed that valuable long-range restraints can be obtained by using synthetic paramagnetic
metal tags. Upon investigation of DTPA-based LCTs that lead tomultiple detected species, DTTA-derived LCTs were envisioned to be
synthesized.
Jiang et al. developed bio-orthogonally linked diethylene-triamine-tetraacetate propyl-1-yne (DTTA-C3-yne) and diethylene-
triamine-tetraacetate butyl-1-yne (DTTA-C4-yne) LCTs that are attached to the protein of interest by the use of a copper-catalyzed
azide alkyne click reaction of an alkyne moiety on the LCT with a p-azido-L-phenylalanine (AzF) residue of the protein (Fig. 7).120
Thereby, the authors demonstrated that large anisotropy parameters can be obtained and RDCs up to 8 Hz were detected using Tb3+
and Tm3+ loaded LCTs on ubiquitin and enzyme II B. Based on intermolecular PCS measured for a UBA1-ubiquitin complex, the
authors reported a refined model on the interactions between the two proteins.
Two further DTTA-derived LCTs equipped with pyridinesulfone linker moieties were reported in 2017 by Chen et al.129 Both the
4PS-PyDTTA and the methyl-substituted analogue 4PS-6 M-PyDTTA were tested on ubiquitin and SrtA constructs and yieldedFig. 7 Copper catalyzed Huisgen azide alkyne cycloaddition of DTTA-C3-yne to a 4-azidophenylalanine residue of the target protein. Remarkably, the triazole ring
forms during the ligation reaction a further coordinating nitrogen site and thereby creates a very short linkage from the LCT to the protein of interest.120 Lanthanoid
tagging via an unnatural amino acid for protein structure characterization. Jiang, W.-X.; Gu, X.-H.; Dong, X.; Tang, C. J. Biomol. NMR 2017, 67, 273–282. Springer.
Application of Paramagnetic LCTs in NMR Spectroscopy 7large PCSs and RDCs. In line with the results of Haberz et al. for the EDTA-derived LCT,127 the authors of the present study
observed a high stability of the nonmethylated lanthanoid complex, i.e. the affinity of the LCT to the lanthanoid ion exceeds the one
of the native calcium binding site in SrtA. Interestingly, 4PS-6 M-PyDTTA was more susceptible to the addition of EDTA than
its nonmethylated analogue.129 However, the methyl substitution leads to a significant increase in the anisotropy
parameters (4PS-6 M-PyDTTA: Dwax ¼ 11.0  10−32 m3 and Dwrh ¼ 3.5  10−32 m3 vs. 4PS-PyDTTA: Dwax ¼ 7.6  10−32 m3 and
Dwrh ¼ 3.0  10−32 m3 for Tm3+ on SrtA D82C), which suggests that the translational and rotational averaging of the paramagnetic
effects by reorientation of the LCT on the surface of the protein is suppressed.
While the DTPA-derived LCTs can lead in theory to observation of up to eight signal sets for each amide in 1H-15N HSQC spectra
and in practice up to five different signal sets were reported, the DTTA-based LCTs equipped with bio-orthogonal and pyridine-
sulfone linker provide one set of signals and yield sizeable anisotropy parameters. Nonetheless, further improvement of the
anisotropy parameters and increase of stability under all buffer conditions remains an interesting target.2.4 TAHA-Based Lanthanoid Chelating Tags
In order to investigate the use of further chelators for the use as LCT in paramagnetic NMR spectroscopy, Peters et al. demonstrated
in 2011 that cysteinyl-phenyl-triaminohexaacetate (Cys-Ph-TAHA) can be used as suitable scaffold for the design and synthesis of
an LCT (Fig. 8).30 Advantageously, Cys-Ph-TAHA is highly symmetric, leads therefore to only one observed set of signals in 1H-15N
HSQC spectra and shows thermal stability over a wide range of temperature (278–315 K). Furthermore, a metal affinity in the
femtomolar range is provided and PCSs up to 2 ppm and RDCs up to 18 Hz are induced by the novel LCT. The authors of the study
conjugated Cys-Ph-TAHA to a 90 kDa complex of Lac repressor protein, deoxyribonucleic acid (DNA) and isopropyl
b-D-1-thiogalactopyranoside (IPTG). A minor disadvantage of the presented LCT is its pH-sensitivity that excludes the use of the
tag for studies at pH values below 4.0, e.g. in order to monitor the unfolding process of a protein of interest under acidic conditions.2.5 IDA-, NTA- and Pyridine-Based Lanthanoid Chelating Tags
Simple, acyclic chelators captivate the interest of researchers due to their cheap and easily accessible precursors. Although it is clear
that the induced anisotropy parameters are expected to be smaller than with extremely rigid, sterically crowded, macrocyclic LCTs,
simple acyclic chelators can constitute an interesting alternative to more advanced LCTs for applications that involve only small-
and medium-sized proteins. Small LCTs are conveniently built from picolinic acid derivatives or iminodiacetic acid (IDA) and
nitrilotriacetic acid (NTA)-scaffolds that are closely related to their larger analogues DTTA and DTPA.18
Su et al. developed a 4-mercaptomethyl-dipicolinic acid (4MMDPA) LCT that yields PCS up to 2 ppm for the Yb3+-complex
when conjugated to the N-terminal domain of arginine repressor protein (ArgN).65 Upon attachment of the LCT to a cysteine
residue in position 68 of ArgN by using Ellman’s reagent, the LCT is further restricted in its mobility relative to the protein surface via
the coordination of a nearby carboxylate of the protein scaffold to the lanthanoid. Closely related to the LCT presented by Su et al.,65
Man et al. reported a 3-mercapto-2,6-pyridinedicarboxylic acid (3MDPA) LCT that bears a shorter linker in the 3-position of the
pyridine instead of the 4-position.130 Upon conjugation of the LCT to ArgN and T4 lysozyme C54T C97AQ69C, the LCT was shown
to yield for such a small-molecule chelator sizeable anisotropy parameters for the Tm3+ loaded construct. As in the case of
4MMDPA, the LCT is suspected to interact with a carboxylic acid group of the Glu21 sidechain of the protein. Jia et al. extended
the repertoire of dipicolinic acid derived LCTs by the design and synthesis of 4MDPA that includes a short linker in the 4-position of
the pyridine scaffold.131 While the tag offers quantitative tagging yields, the obtained anisotropy parameters still offer the potential
of significant advances. In order to enable the measurement of PCS and RDC effect under reductive conditions as e.g. found while
performing in-cell NMR studies, it would be highly desirable to develop a reduction-stable linker moiety based on the dipicolinic
acid LCTs.
Li et al. developed therefore in 2011 a dipicolinic acid-based LCT, which bears a vinylpyridine moiety that reacts in a thiol-ene
reaction with the cysteine thiol of the protein, and was demonstrated to be applicable on both ArgN as well as ubiquitin (Fig. 9).132
The protein–LCT conjugate was shown to be stable both in dithiothreitol (DTT) and 3,30,30 0-phosphanetriyltripropanoic acid
(TCEP) due to the reductively stable thioether that is formed during the tagging reaction. The LCT induces sizeable effects both on
ArgN and ubiquitin constructs.Fig. 8 Chemical structure of the Cys-Ph-TAHA LCT30 synthesized in a total yield of 28% over seven steps.
Fig. 9 Nucleophilic addition of the cysteine residue of a protein via thiol-ene reaction to the LCT reported by Li et al.132 in aqueous solution in order to create a
reduction-stable linkage.
8 Application of Paramagnetic LCTs in NMR SpectroscopySince the interaction of the small molecule chelators with sidechain carboxylates can directly be used in order to immobilize the
LCT on the surface, Swarbrick et al. developed a surprisingly simple LCT based on IDA.133 Upon conjugation to the protein on a
residue in an a-helix via a disulfide-bond, the LCT was shown to interact with an Asp residue in the i + 4 position by its free
coordination sites. The synthesis of the LCT shows an overall yield of 45% for three steps, a result that demonstrates the
straightforward availability of this LCT. However, the presented LCT is not generally applicable, since a basic residue in the i + 4
position, which is either present in the native state of the protein or has to be introduced by mutation, is required. Following the
study with IDA-SH tags, Swarbrick et al. demonstrated that instead of IDA-based tags, also NTA-derived LCTs can be used for the
generation of structural restraints using immobilization by a nearby carboxylate or with a second NTA-LCT in the i + 4 position
resulting in an octadentate coordination motif.134 In order to obtain large structural restraints by additional coordination to the
IDA-SH and NTA-SH LCTs, Yagi et al. determined in a comprehensive study the optimal position of coordinating carboxylate groups
of the sidechain in relation to the tag position.135 While IDA-SH tags require additional coordination in order to yield large PCS,
NTA-SH LCTs can also yield large paramagnetic effects independent of additional coordination by carboxylate groups of the protein.
Interestingly, Loh et al. incorporated an alkyne moiety in both NTA- and IDA-derived LCTs, giving rise to the possibility of bio-
orthogonal tagging reactions, i.e. a copper catalyzed click reaction between the LCT equipped with an alkyne and an azide functional
group of an AzF residue incorporated in the protein.136 Thereby, the authors obtained large anisotropy parameters on a GB1 V21
construct using the alkyne-NTA LCT (Dwax ¼ 16.3  10−32 m3 and Dwrh ¼ 7.8  10−32 m3 for Tm3+) and demonstrated the appli-
cability of the novel LCT by conjugation to AzF-containing constructs of PpiB and ERp29. LCTs that offer the possibility for bio-
orthogonal tagging reactions are generally applicable, even to proteins, that show structural distortions upon introduction of an
additional cysteine or lose their biological activity.
Taking advantage both from vinylpyridine LCTs as well as IDA- and NTA-derived LCTs led to the synthesis of the
4-vinyl(pyridine-2,6-diyl)bismethylenenitrilo tetrakis(acetic acid) (4VPyMTA) LCT by Yang et al.137 Most likely due to the increased
flexibility of the chelator and its pendant arms as well as the flexible linker moiety that can lead to averaging of paramagnetic effects,
the newly developed LCT displays rather small anisotropy parameters. However, in contrast to DTPA-based LCTs, the presented LCT
shows only one set of signals and furthermore, the protein–tag conjugate is stable under reductive conditions and the lanthanoid
complex displays a higher stability than EDTA-lanthanoid chelates.
In order to synthesize a pyridine-derived LCT that providesmore rigid side-arms, Huang et al. developed the 40-mercapto-2,20:60,20 0-
terpyridine-6,60 0-dicarboxylic acid (4MTDA) LCT.138 The reported LCT provides very large anisotropy parameters of
Dwax ¼ 38.9 10−32 m3 and Dwrh ¼ 5.2  10−32 m3 for the Dy3+-loaded chelator on an ubiquitin A28C construct. The large observed
PCSs and RDCs up to 13 Hz can be attributed to additional immobilization of the chelator on the surface of the protein by the
carboxylate bearing sidechain of the residue E24. However, a significant drawback of the reported 4MTDA LCT is the ligation yield of
only 50–70%, which is lower than for the previously described 3MDPA and 4MMDPA LCTs.
In order to provide LCTs that form a reduction-stable thioether bond upon conjugation to the protein, Yang et al. developed the
(4-(phenylsulfonyl)-pyridine-2,6-dicarboxylic acid (4PS-DPA) and 4-phenylsulfonyl-(pyridin-2,6-diyl)bismethylenenitrilo
tetrakis(acetic acid) (4PS-PyMTA)) LCTs.119 The reported LCTs, which are closely related to the 4VPyMTA LCT published by Yang
et al.137 but incorporate a significantly shorter and more rigid linker moiety, yield large anisotropy parameters of
Dwax ¼ −24.5  10−32 m3 and Dwrh ¼ −7.1  10−32 m3 for Dy3+ on a ubiquitin G47C R72A R74A construct.2.6 DOTA-Based Lanthanoid Chelating Tags
Due to the excellent chelation of lanthanoids by DOTA-derived chelators (equilibrium constant for the formation of the Gd3+-
DOTA complex ¼ 1025 M−1 at pH 7)139 that constitutes the main reason for its extensive application inmagnetic resonance imaging
(MRI) as well as radiopharmacy,140,141 the macrocyclic DOTA framework presents an optimal scaffold for the introduction of
various substituents, donor atoms and linker moieties. Furthermore, by three-fold installation of a negatively charged donor
atom, e.g. three lactic acid side-arms, and a noncharged linker donor atom, neutral lanthanoid DOTA complexes can be conve-
niently synthesized and the chance for Coulomb interactions of the LCT with the protein is successfully minimized. Due to the high
affinity towards lanthanoid ions in combination with the possibility to rationally design the LCTs by introduction of suitable side
arms, the DOTA ligand displays very favorable properties for the synthesis of high-performance LCTs.
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pendant arms of the chelator (D and L), form up to four different stereoisomers in solution (D(dddd), D(llll), L(dddd), L(llll))
(Fig. 10), methyl substituents were introduced in order to restrict the conformational flexibility of the ligand.
Häussinger et al. reported in 2009 an eight-fold methyl-substituted LCT (Ln-DOTA-M8-(8S)-SSPy) with a single-armed linker
that leads to very large PCSs over 5 ppm and RDCs over 20 Hz, properties that were unprecedented for single-armed LCTs.29 The
methyl substituents on the basic ring scaffold occupy in an equatorial-upper position128,142 upon coordination of themetal in order
to minimize steric clashes and provide a suitable cavity for the lanthanoid ion. As shown by the authors, the introduction of methyl-
substituents leads to a substantial increase of the conformational stability of the ligand that can be demonstrated in variable
temperature spectra. Furthermore, the LCT can be used under extreme buffer conditions as e.g. strongly acidic pH-values, thereby
enabling to monitor the unfolding of a protein.29 The Tm3+ loaded LCT reported by Häussinger et al. adopts in solution a twisted
square antiprismatic D(dddd) conformation with negligible amounts of the square antiprismatic L(dddd) isomer (9% based on
HPLC detection), while the Dy3+ complex, that adopts a square antiprismatic L(dddd) geometry as major conformation, contains a
more substantial amount of the minor conformational isomer (27%).142
As reported by Joss et al., the occurrence of the minor conformational isomer can be suppressed by an inversion of the
stereochemistry of the side arms that results in exclusive presence of the L(dddd) isomer in the strongly paramagnetic Tb3+, Dy3+
and Tm3+ complexes as well as in the diamagnetic lutetium complex.34 Subsequently, it was demonstrated by Opina et al. for the
Ln-DOTA-M8-(4R4S) complexes, that the observation of the occurrence of only one conformational species, i.e.L(dddd), holds true
for the whole lanthanoid series (the radioactive promethiumwas not investigated).143 Surprisingly, the fitted anisotropy parameters
on ubiquitin and human carbonic anhydrase II constructs both yield that the observed paramagnetic susceptibility of
Ln-DOTA-M8-(4R4S)-SSPy34 is significantly different from the previously published Ln-DOTA-M8-(8S)-SSPy.29 Since both LCTs
are structurally identical apart from the stereochemistry of the side arms and the associated switch in conformational geometry, it
can be concluded that the coordination polyhedron and ligand-metal interactions can lead to a significant change in the induced
anisotropy as suggested earlier for a range of coordination polyhedra by Mironov et al.106
In order to expand the repertoire of DOTA-derived tags and enhance the obtained shifts with DOTA-M8-SSPy LCTs, Joss et al.
introduced isopropyl substituents on the basic ring scaffold (Ln-P4M4-DOTA) and evaluated the performance of the novel chelator
on ubiquitin and human carbonic anhydrase II constructs.36,144 The Ln-P4M4-DOTA LCT induces large PCS of up to 6.5 ppm on
ubiquitin S57C and shows significantly increased anisotropy parameters when compared to its predecessor Ln-DOTA-M8-(4R4S)-
SSPy. A comparison of the different properties of the newly synthesized paramagnetic complexes with Ln-DOTA-M8-(4R4S)-SSPy
showed that the shift range (measured in one-dimensional 1H spectra), position of donor atoms (monitored by DFT calculations)
and translational motion of the LCT on the surface of the protein (modeled with a program developed by Suturina et al.145) are
highly similar for both LCTs. Therefore, it can be concluded that the reason for the strongly enhanced shifts induced by Tm- andFig. 10 Schematic representation of the different conformations of a DOTA-type ligand upon metal coordination and the paths of conversion between the
conformers.142 Reproduced by permission of The Royal Society of Chemistry from Opina, A. C. L.; Strickland, M.; Lee, Y.-S.; Tjandra, N.; Byrd, R. A.; Swenson, R. E.;
Vasalatiy, O. Dalton Trans. 2016, 45, 4673–4687.
10 Application of Paramagnetic LCTs in NMR SpectroscopyDy-P4M4-DOTA when compared to Tm- and Dy-DOTA-M8-(4R4S)-SSPy can be attributed to decreased rotational freedom of the
LCT relative to the protein due to the bulkier isopropyl substituents of the basic ring scaffold.
Since it would be highly desirable to apply rigidified DOTA chelators under reductive conditions as e.g. used for in-cell NMR,
Müntener et al. developed a rigidified DOTA chelate bearing a pyridine-derived linker moiety (Ln-DOTA-(3R4S)-M7Py) that forms
upon conjugation of the LCT to the protein a rigid and stable thioether bond.33 Since the LCT showed only limited reactivity, an
improved version with a fluorine substituent in ortho position of the leaving group was subsequently developed.35
The electron-withdrawing substituent allows to stabilize the Meisenheimer-complex intermediate146 which involves delocali-
zation of negative charge within the aromatic ring during the SNAr tagging reaction. However, the anisotropy parameters are
partially averaged due to the suboptimal placement of the leaving group in the para position of the pyridine linker moiety.
Therefore, a novel pyridinethiazole linker was developed that aligns the main axis of the induced anisotropy with the CPyr-SCys
bond and, thereby, leads to a favorable averaging of the induced anisotropy and hence to strongly enhanced PCSs and RDCs
(Fig. 11).35
In order to further enhance the obtained anisotropy parameters with the pyridinethiazole linker, the methyl substituents on the
macrocyclic ring scaffold were replaced by isopropyl substituents to yield Ln-P4T-DOTA (Fig. 12).37 Ln-P4T-DOTA induces very
large PCS and was benchmarked on ubiquitin S57C, ubiquitin K48C and 15N selectively leucine labeled hCA II S166C constructs
(anisotropy parameters: Dwax ¼ 44.3  10−32 m3 and Dwrh ¼ 4.8  10−32 m3 for Tm3+ on a hCA II S166C construct). Due to its
reduction-stable linker, the LCT could be applied for in-cell NMR studies.37
In order to reduce motional freedom of the LCT on the surface of the protein, a two-point anchored LCT named CLaNP-3 was
reported in 2007 by Vlasie et al.147 In contrast to single-armed LCTs, two-point anchored LCTs yield in general strongly enhanced
anisotropy parameters, since they are significantly more tightly attached to the surface of the protein. However, the expression of
protein constructs that bear two cysteine residues in close proximity and provide thereby the attachment site of the double-armed
LCT is more challenging than the expression of single cysteine mutants, since protein misfolding after expression can more easilyFig. 11 Difference in the attachment point between Ln-M7FPy-DOTA and Ln-M7PyThiazol-DOTA. The more favorable alignment of the CPyr-SCys linkage of
Ln-M7PyThiazol-DOTA leads to a reduced averaging of the induced anisotropy and thus to larger paramagnetic effects observed on the protein.35 Reproduced with
permission from Müntener, T.; Kottelat, J.; Huber, A.; Häussinger, D. Bioconjug. Chem. 2018, 29, 3344–3351. Copyright 2016 American Chemical Society.
Fig. 12 Chemical structure of the L(dddd) conformer of Ln-P4T-DOTA.37 The lanthanoid ion is coordinated by three carboxylate and one pyridine donors and the
sterically demanding substituents rigidify the DOTA scaffold of the ligand. The methylsulfone on the pyridinethiazole moiety serves as leaving group upon reaction of
the LCT with a cysteine residue of the protein.
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to 35 Å away from the metal center were detected. Although the LCT presented by Vlasie et al. shows multiple conformations in
solution that are in exchange with each other, in 1H-15N HSQC experiments only one set of signals for most of the residues is
detected, leading to the successful determination of one set of anisotropy parameters.
After the initial assessment of two-armed DOTA LCTs by Vlasie et al.,147 Keizer et al. synthesized and reported the double-armed,
DOTA-based CLaNP-5 LCT.28,148 The CLaNP-5 LCT presented by Keizers et al. yields large anisotropy parameters of
Dwax ¼ 55.3  10−32 m3 and Dwrh ¼ 6.9  10−32 m3 for Tm3+ and Dwax ¼ 9.0  10−32 m3 and Dwrh ¼ 2.3  10−32 m3 for Yb3+ on
a Paz E51C E54C construct.
Since the CLaNP-5 LCT displays a relatively high, three-fold positive charge, Liu et al. developed the one-fold positively charged
CLaNP-7 LCT that is equipped with two nitro-substituted phenol side arms instead of the two pyridine N-oxide moieties found in
CLaNP-5.121 Upon coordination of the metal, the two phenol groups are deprotonated to give the corresponding phenoxides that
partially compensate the three-fold positive charge of the lanthanoid ion. Interestingly, the anisotropy parameters were found to be
pH-dependent when a histidine residue is located in the immediate vicinity, a behavior that could originate in an apically
coordinated water/hydroxide that can interact with the histidine sidechain.
Subsequently, Liu et al. developed the one-fold positively charged CLaNP-9 LCT that bears two carboxylate side arms.122 The
presented LCT yields large PCS and anisotropy parameters on Paz CuII E51C E54C as well as T4 Lysozyme N55C V57C
(Dwax ¼ 39.5  10−32 m3 and Dwrh ¼ 10.6  10−32 m3 for Tm3+ on the Paz construct and Dwax ¼ 32.5  10−32 m3 and
Dwrh ¼ 15.6  10−32 m3 for Tm3+ on the T4 Lysozyme construct). Although the Yb-CLaNP-9 complex exhibits larger shifts in its
one-dimensional 1H spectrum, it displays smaller anisotropy parameters upon attachment to the protein when compared to
CLaNP-5. This result suggests that the CLaNP-9 LCT shows a slightly enhanced mobility on the surface of the protein, which can be
attributed to the linker that is elongated by 2 Å when compared to CLaNP-5.
In order to decrease the conformational flexibility of the DOTA scaffolds, Graham et al. reported a DOTA-amide LCT that
displays sterically demanding side arms that restrict the flexibility of the basic ring scaffold and side arms of the LCT and thus leads
to only one set of signals in 1H-15N HSQC experiments.31 It is noteworthy, that the shift range in one-dimensional 1H spectra of the
ytterbium complex amounts only to 170.5 ppm, while the LCT induces very large anisotropy parameters of
Dwax ¼ 37.0  10−32 m3, Dwrh ¼ 12.0  10−32 m3, for Ln ¼ Tm3+ on an ArgN protein construct. This result indicates that the
bulky side arms do not only lead to a decrease in flexibility of the macrocyclic scaffold, but also efficiently suppress rotational
averaging of the paramagnetic effects. Besides the introduction of more steric bulk, also shortening of the linker moiety can lead to
significantly enhanced paramagnetic effects observed on the protein.
Lee et al. reported compact, hydrophilic DOTA-based LCTs bearing methyl substituents on the side arms and a short linker
moiety resulting in the formation of a disulfide linkage to the protein.68 The LCT presented by Lee et al. yields large observed
anisotropy parameters on ubiquitin A28C (Dwax ¼ −19.4  10−32 m3 and Dwrh ¼ −7.8  10−32 m3 for Tm3+) and HPPK S112C
C80A (Dwax ¼ 54.5  10−32 m3 and Dwrh ¼ 12.5  10−32 m3 for Tm3+). In order to exploit the advantages of two-point anchored
LCTs, Lee et al. converted both single-armed LCTs from the reported study,68 i.e. the LCTs with a disulfide linker similar to
Häussinger et al.29 as well as the single-armed LCTs with a shorter disulfide linker, into two-point anchored LCTs that yield very
large anisotropy parameters for the Tm3+-loaded LCT on the tested ubiquitin E24C A28C and HPPK K76C C80 constructs
(Fig. 13).123,124Fig. 13 Chemical structures of the Ln-T1 and Ln-T2 and isosurfaces induced by the Tm3+-loaded LCTs attached to a HPPK K76C C80 construct.123 Reproduced by
permission of The Royal Society of Chemistry from Lee, M. D.; Dennis, M. L.; Swarbrick, J. D.; Graham, B. Chem. Commun. 2016, 52, 7954–7957.
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pH-dependent, i.e. the induced shifts at pH 6.5 are 40% smaller than the ones observed at pH 8.0.123 This feature could be
attributed to the hydroxyl donor groups, since for the related single-armed Ln-DOTA-M8-(8S)-SSPy LCTs equipped with carboxy
groups, the pH dependence of the induced anisotropy was found to be not significant by Strickland et al. in the pH range of
5.0–7.4.70 However, the pH sensitivity of the reported LCTs by Lee et al.123 was not found for the LCTs with hydroxyl donor groups
and a shortened linker,124 therefore other reasons than the hydroxyl groups may be involved in the observed pH-dependence.
In order to provide reductively-stable linkages that can be applied, e.g. in in-cell NMR, the attachment of the LCT to a AzF residue
incorporated in the protein via copper catalyzed azide-alkyne click reaction provides a very valuable solution.67 Loh et al. reported two
different DOTA-based LCTs with different linker lengths. For the shorter alkyne linker presented in the study, the triazole-moiety
formed upon reaction of the alkyne group on the LCT with the azide side chain directly serves as donor to the lanthanoid ion after
successful conjugation reaction. Both LCTs induce sizeable anisotropy parameters on a ubiquitin Glu18AzF construct with Tm3+ or
Tb3+-loaded complexes. Importantly, the used protein must tolerate free copper ions used for the catalysis of the conjugation reaction.
Therefore, protein constructs with His6 tags are usually not suitable for ligation reactions with the described methodology.
A further example of an LCT yielding a reduction-stable linkage upon conjugation constitutes the iodoacetamide LCT
Ln-M8-CAM-I reported by Hikone et al., which incorporates a carbamidemethyl linker with an iodide leaving group on an acetyl
amide moiety that reacts as electrophile with the nucleophilic thiol group of cysteine residues of the protein.95 In order to
demonstrate the suitability of the LCT derived from Ln-DOTA-M8-(8S)-SSPy29 for in-cell NMR studies, Hikone et al. ligated the
newly developed LCT to ubiquitin S57C and introduced the tagged constructs successfully into HeLa cells via electroporation. The
derived anisotropy parameters (Dwax ¼ 4.0  10−32 m3 and Dwrh ¼ 1.8  10−32 m3 for Dy3+ at 310 K) demonstrate the suitability of
the reported construct for in-cell NMR, however, the magnitude of the anisotropy parameters is significantly smaller than for
Ln-DOTA-M8-(8S)-SSPy (Dwax ¼ 19  10−32 m3 and Dwrh ¼ 11  10−32 m3 for Dy3+ at 313 K), which can be attributed to the
significantly longer and therefore more flexible iodoacetamide linker.29,95
Yang et al. presented in 2016 an LCT that yields extremely large anisotropy parameters and PCSs on an ubiquitin G47C construct
(Dwax ¼ −84.3  10−32 m3 and Dwrh ¼ −17.2  10−32 m3 for Dy3+ and Dwax ¼ 65.2  10−32 m3 and Dwrh ¼ 31.8  10−32 m3 for
Tm3+).32 The large PCSs are highly desirable for evaluation of challenging applications involving large biomacromolecules,
however, due to the nonstabilized Meisenheimer complex146 during tagging reaction of the cysteine with the pyridinesulfone
moiety, the LCT requires severely basic tagging conditions, i.e. pH 9.0–9.3 over a time of 16–18 h. For a successful application of the
strongly paramagnetic LCT, only proteins withstanding these harsh conditions can be investigated.
In order to attach LCTs to other biomacromolecules than proteins, Wu et al. developed a bromoacetamide linker that was
demonstrated to be able to ligate to DNA incorporating a phosphorothioate modification.72 However, conjugation to an internal
phosphorothioate in DNA generates an additional stereocenter, i.e. a stereogenic phosphorus atom, in racemic form and hence to
two sets of diastereotopic NMR signals. In the reported case, the two diastereomers can be successfully separated using conventional
reverse-phase HPLC. PCSs were extracted from 2DNOESY spectra and fitted to a structural model of the DNA double-helix based on
fiber diffraction data in order to give the first anisotropy parameters that were obtained by using an LCT with a covalent linkage
to DNA.
The discussed examples in this section highlight the outstanding properties of DOTA-type ligands for the development of
tuneable, strongly paramagnetic LCTs with a diverse range of linker and activator moieties and their subsequent application in
structural studies of protein–ligand complexes.3 Applications of Lanthanoid Chelating Tags in the Localization of Ligands Within Biomacromolecules
3.1 Introduction
The localization of ligands within biomacromolecules is crucial for the understanding of the cellular machinery and the underlying
processes. Furthermore, the positioning and orientation of a ligand within a drug target is an important prerequisite for rational
design of drug molecules. In contrast to X-ray crystallography, which provides in principle a precise tool for the determination of
ligand-protein complexes, the use of NMR spectroscopy allows for monitoring of biomacromolecule-ligand interactions under
physiologically relevant conditions. While NOESY experiments are optimally suited for monitoring distances below 5–8 Å and
require a full NMR assignment obtained from multidimensional experiments by using isotopically labeled biopolymers, CSP can
result in misleading conclusions due to conformational changes or unexpected intermolecular interactions of the biomacromole-
cules. The exploitation of PCS for the characterization of biomacromolecule-ligand complexes can cover large distances beyond
100 Å with high accuracy. Furthermore, if the anisotropy parameters from multiple sites have been determined, the accordingly
tagged protein constructs can be used with a large number of ligands, thus providing a valuable tool for screening of potential drug
molecules.3.2 Weakly Binding Ligands
In order to determine the position of a weakly binding ligand within a protein that is in fast exchange, the ligand shifts can be
conveniently obtained from one-dimensional NMR experiments. Since the ligand can be employed in excess, the signal discrim-
ination between ligand resonances and protein peaks is ensured by the intensity and the PCS can be extracted from the observed
Fig. 14 Localization of ligands within a protein scaffold (predicted metal positions: magenta, experimentally determined metal positions: orange, NOE-based
ligand positions: green, ligand positions determined by PCS: orange, ligand position determined by use of predicted anisotropy parameters: magenta). Fitted ligand
position based on experimental data is in accordance to NOE position, with simultaneous occurrence of a “ghost” site during the fitting process (A). Fitted ligand
position based on predicted anisotropy parameters (B).40 Reproduced with permission from Guan, J.-Y.; Keizers, P. H. J.; Liu, W.-M.; Löhr, F.; Skinner, S. P.;
Heeneman, E. A.; Schwalbe, H.; Ubbink, M.; Siegal, G. J. Am. Chem. Soc. 2013, 135, 5859–5868. Copyright 2013 American Chemical Society.
Application of Paramagnetic LCTs in NMR Spectroscopy 13shift for the fast exchanging bound and unbound fraction of the ligand provided the affinity is known, and the PCS is large
compared to the CSP. Saio et al. determined the positioning of low affinity ligands within the growth factor receptor-bound protein
2 Src homology domain by use of PCS analysis.102 The paramagnetic shifts were induced by a lanthanoid-binding peptide tag
attached via two linkages on the N-terminus and one cysteine mutant in the protein. Upon determination of the anisotropy
parameters, the weakly binding pYTN tripeptide ligand and the tagged protein construct were combined and the PCS were extracted
from the determined averaged shift of the unbound and the bound state using the binding affinity of the tripeptide to the protein
obtained from a 1H-15N HSQC-based titration.
The combination of the structural restraints obtained by PCS analysis and docking simulations yielded then the position of the
ligand within the biomacromolecule. In 2013, Guan et al. presented the localization of ligands using PCS analysis using the rigidly,
two-point anchored LCT CLaNP-5 attached to three different sites of the protein.40 Interestingly, two-point anchored LCTs as
CLaNP-5 that are strongly immobilized on the surface of the protein, yield reproducible and predictable anisotropy parameters
(Fig. 14). This leads to the convenient feature that the predicted Dw parameters can be directly used for a coarse grain localization of
the ligand within the biomacromolecule (RMSD of 4.4–4.7 Å relative to NOE structure). Hence, for an initial assessment or
discrimination of two already established binding sites in a protein, no isotopically labeled protein or backbone amide assignment
is required and the only input required is the PCS from one-dimensional 1H experiments. The authors reported that upon the
paramagnetic labeling of the protein on three different sites and fitting of the anisotropy parameters based on backbone amide
NMR shifts, the ligand can be localized and positioned over a distance of 15–25 Å with an average root-mean-square deviation
(RMSD) of 2.8 Å when compared to the NOE structure. In contrast to the attachment of the paramagnetic tag to the biomacromo-
lecule of interest, as demonstrated by Brath et al., the LCT can also be directly attached to the weakly binding ligand.149 Thereby, the
authors identified the interaction site of calmodulin with a low-affinity anesthetic agent. However, although the direct attachment
of the LCT to the ligand of interest has the advantage that dissolution of hydrophobic ligands is enhanced in aqueous solution and
engineering of protein cysteine mutants is omitted, the approach reported by Brath et al. is less suitable for the screening of a large
number of different ligands, since the LCT would have to be synthetically coupled to each of the applied ligands.3.3 Ligands in the Intermediate Exchange Regime
Ligands in the intermediate exchange regime can pose significant challenges for PCS NMR approaches, since their resonances are
often broadened beyond detection and therefore no structural restraints can be measured. An elegant tool to circumvent this
difficulty is the use of the chemical saturation exchange transfer methodology (CEST) as proposed by Gao et al.150 The authors of
the study suggested to detect the PCS on the spectrum of the free ligand by scanning through the 19F saturation frequencies of the
bound state. Since intensity dips can be observed at the frequencies of the signals of the bound ligand, a fluorine spectrum of the
bound ligand can thereby be collected. The authors of the study then used the PCS recorded by use of their 19F CESTmethodology in
combination with PCS-driven docking programs as HADDOCK or XPLOR-NIH containing the PARArestraints module in order to
localize mono- and difluorinated inhibitors in the BRM bromodomain.
In order to extend the presented method by Gao et al.150 for the localization of ligands with micromolar affinities and NMR
resonances in the intermediate exchange regime that do not incorporate fluorine, Xu et al. developed a new method that is suitable
for localization of ligands withmicromolar affinities.151 Since 1H CEST usually is not applicable in a clean fashion, since it can suffer
severely from NOE interferences, Xu et al. proposed the use of relaxation dispersion (Fig. 15). By application of their novel
methodology, the authors obtained PCS restraints and used them successfully as input restraints in docking simulations of the
ligand within the protein.
Fig. 15 Extraction of PCS measured on ligands in the intermediate exchange regime by use of relaxation dispersion.151 Reproduced with permission from Xu, D.;
Li, B.; Gao, J.; Liu, Z.; Niu, X.; Nshogoza, G.; Zhang, J.; Wu, J.; Su, X.-C.; He, W.; Ma, R.; Yang, D.; Ruan, K. J. Phys. Chem. Lett. 2018, 9, 3361–3367. Copyright
2018 American Chemical Society.
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In the localization of strong ligands, usually large PCS can be detected, since the observed signal originates exclusively from the
bound state that experiences the full PCS and not an average shift of the bound and unbound state as in the case of the weakly
binding ligands in fast exchange. However, the signal discrimination of the bound, strongly binding ligand against the signals of the
protein, which is present in equimolar amounts within the sample, bears a significant challenge. Besides the equimolar ratio and
therefore similar shift intensities, tightly binding ligands exhibit the same rotational correlation time as the signals of the protein
and are therefore broadened in similar extent. Isotopic labeling of the ligand, e.g. with 13C atoms, is certainly achievable, however,
for a large number of ligands that have to be screened against a protein of interest this cannot be considered as a convenient
approach. Saio et al. achieved the required signal discrimination by deuteration of the protein and measurement of one-
dimensional 1H spectra.102 Thereby, the authors were able to localize a high-affinity inhibitor of the Src homology 2 domain of
the growth factor receptor-bound protein 2 by use of the observed PCS and docking simulations over a distance of 10 Å.
An approach for overcoming the issue of signal discrimination of strongly binding ligands was proposed by Chen et al., who
used a tert-butyl group, which displays a strong signal with a specific NMR shift, as reporter group for detection of the signal of the
bound ligand (Fig. 16).152
The researchers found that broadening and simultaneous shift of the signals due to the paramagnetic tags can lead to ambiguous
assignments caused by insufficient signal discrimination when compared to the protein. However, the tert-butyl group incorporated
in the ligand produces very intense NOESY correlations even when the protein is hardly detectable. Thereby, the signals of the ligand
can be unambiguously assigned and discriminated towards the protein background. Since the used approach omits the need for
perdeuteration of the protein samples and spectra can be acquired at very low concentration, which is important for screening of a
large number of ligands, the methodology reported by Chen et al. is highly suitable for all ligands containing tert-butyl groups.
In order to unambiguously localize fluorine-containing ligands over large distances, Zimmermann et al. developed an approach
based on the acquisition of one-dimensional 19F spectra with paramagnetic tags attached to different mutation sites on the protein
scaffold.41 This methodology will be described in the next section, which covers the enzyme human carbonic anhydrase II and the
localization of ligands within the protein by PCS, and lies at the heart of the present case study.Fig. 16 Strong correlation peaks of the tert-butyl group of the applied, strongly binding ligand (right). Structural models of the protein–ligand complex of DENpro
and ligand 1. The fitted regions with a deviation less than 0.02 ppm from the experimental PCSs are indicated with color coding: tert-butyl group (magenta), aromatic
protons (purple and cyan).152 Reproduced with permission from Chen, W.-N.; Nitsche, C.; Pilla, K. B.; Graham, B.; Huber, T.; Klein, C. D.; Otting, G. J. Am. Chem. Soc.
2016, 138, 4539–4546. Copyright 2016 American Chemical Society.
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4.1 Human Carbonic Anhydrase and Its Use in the Development of Artificial Metalloenzymes
Human carbonic anhydrase II (hCA II) is a medium-sized, monomeric, globular protein with a molecular weight of 29 kDa. hCA II
catalyzes the reversible hydration of CO2 to bicarbonate and displays a catalytic turnover rate of kcat ¼ 1.4  106 s−1 and an
efficiency of kcat/KM of 1.5  108 M−1 s−1, which rank among the highest known for enzymatic reactions and can be considered
to be close to the limit imposed to the reaction by diffusion.153–156 The reaction is best described by a two-step mechanism.156 First,
CO2 is directly attacked by the zinc bound hydroxide ion to form a metal bound bicarbonate, which is then replaced by a water
molecule in order to release the bicarbonate anion from the zinc metal center. In the second step, a proton from the zinc bound
water molecule is transferred, using a histidine residue as proton shuttle, to the aqueous solvent surroundings in order to regenerate
the zinc bound hydroxide. The central zinc(II) ion of hCA II is coordinated by three histidine residues and one hydroxide ion in a
distorted tetrahedral geometry in order to form together the active site. The active site itself is located at the bottom of a conical
shaped cavity, which is about 15 Å deep and 15 Å wide at the entrance. The cavity leading to the active site comprises a hydrophilic
and a hydrophobic side.157 The Zn(II) ion in combination with the hydrophobic side is the binding site for virtually all hCA II
inhibitors.156 An interesting structural feature displayed by hCA II is the knot-like topology, i.e. if one were to pull at both ends of
the peptide chain, a knot would form (Fig. 17).157
In order to use hCA II as a drug target, high affinity inhibitors of hCA II have been developed.156 Strongly binding inhibitors of
hCA II are based on an aromatic sulfonamide functional group within the ligand.158,159 The strong binding affinity originates in the
ability of the sulfonamide anion (RS(O)2NH
−) to strongly coordinate the zinc ion.160 The properties of the inhibitor can be tailored
by adjusting the aromatic ring and adding different functional groups to the aromatic scaffold.156 Importantly, the inhibition of
hCA II allows the control of different diseases, e.g. glaucoma, a disease that results in nerve damage followed by a loss of the
patient’s vision. hCA II plays an important role in the control of the intraocular pressure. The conversion of CO2 into bicarbonate
catalyzed by hCA II in the ciliary body causes the uptake of sodium ions and thus also water into the eye. The sodium ions together
with water, other electrolytes and components as amino acids and glutathione form the aqueous humor. Increased intraocular
pressure is one of the most important risk factors for glaucoma. The inhibition of hCA II suppresses the formation of bicarbonate,
which results in less uptake of sodium ions and water and thus leads to a reduction of the intraocular pressure.161
The large binding pocket of hCA II in combination with strongly binding and readily derivatizable inhibitors rendered hCA II
likely to be an optimal scaffold for artificial metalloenzymes. Additionally, hCA II is easily overexpressed and is therefore highly
suitable for an optimization by directed evolution in order to improve the performance of the organometallic protein construct.
By today, directed evolution has become a highly advanced technique that can be readily used in order to optimize the catalytic
properties of computationally designed enzyme folds or of proteins with promiscuous activity that are auspicious catalysts for other
than only their natively catalyzed reaction.162–164 Transition metal complexes can be anchored to hCA II by tethering a bidentate
ligand to an aryl-sulfonamide inhibitor.165 Iridium-based piano stool complexes incorporated into hCA II were then shown to be
able to catalyze an asymmetric transfer hydrogenation of imines.166 Subsequently, the catalytic performance was improved by
computational design, which led both to an increase of the enantioselectivity (70–96% ee) as well as the turnover number (9–59)
(Fig. 18).167Fig. 17 View on the fold of hCA II displayed as ribbon structure (a-helices: red, b-sheets: blue). The active site Zn(II) ion is coordinated by three histidine residues,
and lies at the center of the enzyme. Furthermore, the critical residues for the initiation of folding of hCA II are marked within the displayed structure.156 Reproduced
with permission from Krishnamurthy, V. M.; Kaufman, G. K.; Urbach, A. R.; Gitlin, I.; Gudiksen, K. L.; Weibel, D. B.; Whitesides, G. M. Chem. Rev. 2008, 108,
946–1051. Copyright 2016 American Chemical Society.
Fig. 18 View on the active site of an artificial metalloenzyme incorporating an sulfonamide iridium piano stool complex for efficient, asymmetric catalysis in the
synthesis of (S)-salsolidine, an inhibitor of monoamine oxidase. The H-bonds introduced using computational design are marked with dashed lines.167 Reproduced
with permission from Heinisch, T.; Pellizzoni, M.; Dürrenberger, M.; Tinberg, C. E.; Köhler, V.; Klehr, J.; Häussinger, D.; Baker, D.; Ward, T. R. J. Am. Chem. Soc.
2015, 137, 10414–10419. Copyright 2016 American Chemical Society.
16 Application of Paramagnetic LCTs in NMR SpectroscopyIn a following study, in vivo transfer hydrogenation enabled by iridium catalysts incorporated into the hCA II scaffold was
investigated.168 Furthermore, computational studies elucidating the amino acid residues, which contribute significantly to the
binding of the ligands,159 as well as comparing both point-charge and atomic multipole-scored methods for studying the binding of
sulfonamide ligands to hCA II were reported.169 One of the most promising fields of applications for metalloenzymes is their ability
to activate drugs at a specific target location in vivo. This could be used to specifically target cancer cells, since cancer cells overexpress
carbonic anhydrase IX in order to arrange with acidosis due to their strongly accelerated and anaerobic metabolism.170 In this
context, the ring-closing metathesis (RCM) constitutes a promising reaction as it allows the bioorthogonal conversion of acyclic
diolefins to cyclic products. By use of hCA-based artificial metalloenzymes, RCM can be performed by anchoring a second-
generation Hoveyda-Grubbs catalyst to the active site of the protein using an arylsulfonamide part on the catalyst.171
The same properties that render hCA II as an interesting host for metalloenzymes also result in an excellent suitability as test
protein for biophysical studies of protein–ligand binding.156 The convenient derivatization of the inhibitors in combination with
reported X-ray structures of protein–ligand complexes pose hCA II as an excellent choice in order to develop newmethods of ligand
localization. In order to localize ligands for hCA II within the protein scaffold in solution, a method based on paramagnetic NMR
spectroscopy was developed.41 More specifically, 19F detected, lanthanoid-induced PCSs served as structural restraints in order to
localize the ligands of interest within the protein scaffold in solution resulting in an accuracy of up to 0.8 Å over a distance of
22–38 Å.4.2 Localization of Ligands within Human Carbonic Anhydrase II—Introduction and Concept
Localization of ligands within proteins in solution is crucial to the rational design of drugs and investigation of biomedical
pathways within the cellular machinery. In order to study the structure of ligand-protein complexes that are not straightforward
amenable to X-ray crystallography172 as well as cryo-electron microscopy173 and in order to get insights into the dynamics of the
complexes, NMR spectroscopy and in particular paramagnetic NMR spectroscopy constitutes a highly promising method.18 As
discussed in the previous section, the localization of firmly binding ligands within proteins in solution using NMR poses significant
challenges as signal discrimination and the short distance range covered by conventional NMR spectroscopy. Given the three-
dimensional structural restraints and distance dependency of R−3 displayed by PCSs, they deliver an optimal tool for the calculation
of the ligand position within the protein based on long-range restraints and can thereby overcome the distance limitation of NOE
experiments and unspecific results by CSP. Furthermore, during the screening process of the ligands, the protein is not required to be
labeled, since only the ligand PCS is used, detected from one-dimensional spectra. In order to achieve signal discrimination between
the signals of a strongly binding ligand and the protein, different approaches where already implemented. Saio et al. used
deuterated protein samples in order to conveniently detect the signals of the ligand.102 In order to remove the need for protein
labeling, Chen et al. proposed to use a tert-butyl substituent as suitable reporter group, since in NOESY spectra exceedingly strong
correlations are detected for the tert-butyl group, even when the protein correlations are barely visible.152 Since the percentage of
drugs incorporating fluorine amounted to 25% in 2014174 and the fluorine detection removes the need for protein labeling while
giving an astonishingly high sensitivity due to the favorable gyromagnetic ratio and the 100% natural abundance of the NMR active
isotope, we envisioned in our study to introduce a fluorine-detected localization of ligands within proteins using PCSs as structural
restraints.41 In order to test our approach, we incorporated three different, strongly binding sulfonamide ligands within hCA II
(Fig. 19).
Fig. 19 hCA II inhibitors for the evaluation of the 19F-PCS-based approach for localization of ligands within proteins.
Application of Paramagnetic LCTs in NMR Spectroscopy 17For the unambiguous localization of a ligand within a protein scaffold in three-dimensional space, PCSs from different tagging
sites are needed. Alternatively, a smaller number of tagging sites can be used in combination with different LCTs that yield
independent anisotropy tensors. By using multiple tagging sites, first, the anisotropy parameters for each tagging site are fitted by
using the backbone amides. Upon detection of the PCSs on the ligand signals, the values are compared with the back-calculated
positions for a given PCS derived from the fitted anisotropy parameters depicted as isosurfaces around the paramagnetic center.
Intersection of two isosurfaces from two different positions yields a curve that includes the possible ligand positions (Fig. 20).
By use of a third isosurface, the curve gets intersected at two different points that depict the remaining two possible positions for the
ligand position. Intersection with a fourth isosurface leads then to one point in space as unique solution for the fluorine atom.
However, since monitoring the ligand position from three different tagging sites results in two possible locations and often one of
these possibilities is located completely outside the protein scaffold or in very dense regions in the interior of the protein, in practice
usually a fourth position is not required to determine unambiguously the position of the ligand within the protein.
In order to obtain different tagging sites for attachment of the LCTs, five serine to cysteine mutations were introduced on the
surface of the protein: S50C, S166C, S173C, S217C and S220C. Furthermore, different labeling schemes were introduced, each with
its own purpose: uniformly 15N labeled hCA II for the determination of the anisotropy parameters from 1H-15N HSQC spectra and
selectively 15N leucine labeled hCA II in order to serve as starting point for the fitting process due to crowded paramagnetic spectra.
The 26 leucine residues in hCA II show a favorable distribution in the primary sequence, amount to 10% abundance and the
chemical shift dispersion in 1H-15N HSQC experiments is reasonable as expected for a well-folded, globular protein. Upon tagging
with a diamagnetic LCT, a small number of residues close to the tagging site are shifted. In order to contribute for the occurrence of
these shifts, we attached, besides the paramagnetic Tm3+-loaded LCT, also the diamagnetic Lu3+-loaded LCT to the protein in order
to acquire reference spectra. Furthermore, in order to provide complete evidence for the assignment of the shifted residuesFig. 20 Intersection of different isosurfaces for the localization of a specific nucleus within a protein scaffold using experimental and back-calculated PCS: A single
isosurface plotted besides hCA II (top left), intersection of two isosurfaces originating from PCS measured from two different sites within the protein and their curve of
intersection (top right), intersection of three isosurfaces resulting in two intersection points (bottom left, first intersection point observable in the center of the protein
scaffold, the second on the backside of the protein), intersection of four isosurfaces resulting in one and thus unambiguous intersection point (bottom right).41
Reproduced by permission of The Royal Society of Chemistry from Zimmermann, K.; Joss, D.; Müntener, T.; Nogueira, E. S.; Schäfer, M.; Knörr, L.; Monnard, F. W.;
Häussinger, D. Chem. Sci. 2019, 10, 5064–5072.
Fig. 21 Strongly paramagnetic LCTs applied in the localization of ligands within hCA II. Ln-DOTA-M8-(8S)-SSPy in△(dddd) and Ln-M7-(3R,4S)-PyThiazole-DOTA
in L(dddd) conformation (see also Section 2.6).29,35
18 Application of Paramagnetic LCTs in NMR Spectroscopyupon tagging reaction, we produced a triple labeled mutant that was then used for backbone assignment with and without attached
Lu3+-LCT.
Upon a successful assignment of the backbone of hCA II, the anisotropy parameters induced by the LCTs ligated to different
attachment sites can be determined by fitting the amide signals detected in 1H-15N HSQC experiments to the X-ray structure of hCA
II. Since the uniformly 15N labeled protein displays crowded spectra, selectively 15N leucine labeled mutants are used to provide a
reasonable starting point for the fitting routine. Full assignment of the PCS and fitting to the X-ray structure leads then to the derived
anisotropy parameters. After fitting of the anisotropy parameters, the protein is incubated with the ligand of interest and excess
ligand is subsequently removed by simple centrifugation. By acquiring one-dimensional 19F experiments, the PCS of the fluorine
atoms incorporated in the ligand can be measured. Back-calculation of the expected values in different positions in the protein by
use of the previously fitted anisotropy parameters from multiple tagging sites leads then straightforwardly to the positioning of the
ligand within the protein. Since large PCS decrease significantly the error and lead to more precise structural restraints, an LCT is
required that induces large PCS and is suitable for exploration of the hCA II scaffold that is characterized by a diameter of 40–56 Å
and a molecular weight of 30 kDa.156 We used the eight-fold methyl-substituted Ln-DOTA-M8-(8S)-SSPy29 and the recently
published Ln-M7PyThiazole-DOTA,35 which incorporates a short and rigid pyridinethiazole-derived linker moiety (Fig. 21).4.3 PCS Analysis and Determination of the Anisotropy Parameters from Multiple Positions Within the Protein
The PCS and the corresponding anisotropy parameters are generated by the attachment of an LCT to the protein scaffold onmultiple
positions. In order to generate valuable structural restraints, a few criteria have to be met: (i) The LCT needs to be attached in a stable
and rigid position relative to the protein. (ii) The global fold of the protein must not be compromised by the attachment of the LCT.
(iii) The attachment sites should be distributed all over the protein in order to achieve a reasonable orthogonality of the different
induced anisotropy parameters and the corresponding isosurfaces. In order to meet all of the mentioned criteria, five solvent-
exposed serine residues in various positions of the protein located in stable secondary structure elements were mutated in order to
produce five different cysteine mutants (Fig. 22). The native cysteine 206 present in human carbonic anhydrase II was mutated vice
versa into a serine residue.
The PCS methodology requires a backbone assignment of the protein, in the best case a backbone assignment of the
diamagnetically tagged protein in order to avoid ambiguities caused by shifted residues close to the tagging site, and therefore a
backbone assignment of uniformly 2H 13C 15N labeled hCA II S50C Lu-DOTA-M8 was performed. With the assigned amide
resonances for the diamagnetic spectra in hand, the shifted residues due to PCSs are assigned. Based on the experimentally observed
PCS on the amide resonances frommultiple tagging sites and the structure of the protein, the anisotropy parameters induced by the
LCT for each tagging site can then be fitted. However, due to the crowded 1H-15NHSQC spectra of uniformly 15N labeled hCA II, the
direct assignment of all PCS can be cumbersome (Fig. 23).
In order to reduce the chance of obtaining an erroneous PCS assignment, multiple approaches were developed: (i) selectively
labeled proteins, (ii) variable temperature NMR or (iii) use of different lanthanoids.
Selectively labeled proteins, e.g. selectively 15N leucine labeled proteins as used in this study, decrease drastically the complexity
of the 1H-15N HSQC spectra (Fig. 24). The assignment of the shifted resonances in the spectra with reduced complexity that are
therefore more amenable to PCS analysis leads then to an initial set of anisotropy parameters. The back-calculation of the remaining
unassigned PCS based on the initially derived anisotropy parameters then strongly facilitates the complete assignment.
Measurement of PCS at variable temperatures produces a series of differently shifted signals, since PCSs are temperature
dependent and, in addition, an increase in temperature leads to enhanced movements of the LCT on the surface of the protein
and flexibility of the protein scaffold, which results in decreased PCS. The thereby produced pattern of signals significantly
simplifies the assignment due to the “linkages” provided between the diamagnetic shift and the paramagnetic shift at room
temperature (Fig. 25).
A very similar approach involves the application of different lanthanoid ions. The major determinants of the strength of the
induced PCS are the intrinsic anisotropy of a lanthanoid within a given ligand-field/chelator and its motion on the surface of the
protein. Since the motion can be expected to be similar for all different lanthanoids, except for very rare cases (when a larger
Fig. 22 Cysteine mutations introduced in the hCA II samples visualized in the X-ray structure of hCA II (PDB 3KS3,175 introduced cysteine mutations: red, native
cysteine 206 (mutated to serine): yellow, leucine residues: blue, zinc(II) ion: brown).41 Reproduced by permission of The Royal Society of Chemistry from
Zimmermann, K.; Joss, D.; Müntener, T.; Nogueira, E. S.; Schäfer, M.; Knörr, L.; Monnard, F. W.; Häussinger, D. Chem. Sci. 2019, 10, 5064–5072.
Application of Paramagnetic LCTs in NMR Spectroscopy 19lanthanoid ion would enable coordination of a protein sidechain on the ninth coordination site and a smaller lanthanoid would
not show this effect), the complexation of different lanthanoids and attachment of the different LCTs to the protein leads to a
pattern of signals similar to the measurement at various temperatures. The pattern of the shifts induced by application of different
lanthanoid ions can then be used for a convenient assignment of the PCSs (Fig. 26).
The selective labeling approach is usually for severely crowded 1H-15N HSQC spectra the more convenient choice, since the
variable temperature approach and application of a series of lanthanoids even increase the complexity of the overlaid spectra in
strict technical terms.
Therefore, selectively 15N leucine labeled hCA II mutants were expressed and led in combination with the assignment of
uniformly labeled hCA II tagged with Lu-DOTA-M8 to an initial fitting of the acquired PCS. Based on the leucine derived tensor
parameters, the PCS of the remaining residues of the uniformly 15N labeled hCA II were back-calculated and the experimentally
measured PCS fitted to the structure (PDB 3KS3)175 using the software Numbat.97 A full description of the fitting routines can be
found in the supporting information of the original publication.41
The complete results of all hCA II constructs tagged with Tm-DOTA-M8 are depicted in Table 1. Importantly, in order to obtain
an estimation of the error included in the fitted anisotropy parameters, two different Monte-Carlo approaches can be applied. While
the first one uses a structure variation during the fitting process, the second one uses only subsets of PCS to account for the
possibility that erroneous assignments are hidden due to the good quality of the rest of the fitted resonances. Subsequently, two
different criteria can be used to assess the quality of the fits. First, the location of the metal center obtained in a fit without used
restraints in a reasonable positioning to the cysteine residue and in a distance of 6–8 Å to the g-oxygen confirms the metal position
found by the fitting routine. Second, the Q-factors give an impression about the quality of an obtained fit. The Q-factors for the used
LCTs29,35 and hCA II constructs were found to be excellent (0.035–0.106). The complete fits of all PCS observed with the
Tm-DOTA-M8-SSPy29 and Tm-Thiazole35 LCT constitutes the basis for an accurate back-calculation/prediction of the 19F PCS
observed on the ligands and thus their localization within the protein. For the Tm tagged S166Cmutant, significantly larger PCS and
anisotropy parameters were found than for the other constructs. This result can be assigned to a different environment of the tagging
site that causes a different flexibility of the LCT on the protein.145
With the full set of fitted PCS from various attachment sites in hand, the localization of the ligands can be tested by incubation of
the tagged hCA II constructs with the three different ligands. The high-affinity phenyl-sulfonamide ligand molecules (FM-519,
FM-510 and F2-Inh) were added to the buffered protein sample as a solution in DMSO in small excess (1.1 eq.) and the incubated
protein was then washed several times with buffer in order to remove any excess ligand. The protein was then concentrated and
subjected to 1H-15N HSQC experiments that confirmed the complete loading and the structural integrity of the protein.4.4 Measurement of 19F PCS and Localization of the Ligand Using a Monte-Carlo Approach
19F PCS were observed in simple one-dimensional 19F experiments for all ligand-containing protein constructs (Fig. 27). Due to the
strongly paramagnetic LCTs, sizeable PCS of up to 0.4 ppm were detected, ensuring that only a minimal error is included in the PCS
that serves as raw data input for the fitting process of the ligand position. The linewidths of the fluorine signals in the range of
20–70 Hz indicate clearly residual mobility of the phenyl ring of the ligand that points out of the enzyme’s pocket, since
comparable strongly binding carazolol ligands showed linewidths of 220–230 Hz in a study of Eddy et al.176 and the Debye-
Waller factors of the PDB 1G54 agree with this observation.177 As for the amide NdH spin pairs, the largest PCSs were observed for
the Tm-tagged hCA II S166C constructs, most likely due to the suppressed flexibility of the LCT attached to this mutant when
compared to the other attachment sites.145
By using the obtained anisotropy parameters from the fitting to the backbone amides of the hCA II constructs, the expected 19F
PCS can be back-calculated and an estimate of the position of the ligand can be achieved. The expected PCS for given anisotropy
parameters in relation to the distance and angular position of the fluorine atom of the ligand can be calculated using the following
equation:
Fig. 23 Overlay of the 1H-15N HSQC spectra of uniformly 15N labeled hCA II S50C Lu-DOTA-M8-SSPy (black) and hCA II S50C Tm-DOTA-M8-SSPy (red) recorded at
600 MHz proton frequency (Aliased signals with negative intensity are shown with dashed contour lines, PCS are indicated with solid and NH2 groups with dashed
lines, water signal was omitted for clarity). Due to the highly crowded overlay of the spectra, an ambiguous result could be obtained upon direct assignment of all
PCS.41 Reproduced by permission of The Royal Society of Chemistry from Zimmermann, K.; Joss, D.; Müntener, T.; Nogueira, E. S.; Schäfer, M.; Knörr, L.;
Monnard, F. W.; Häussinger, D. Chem. Sci. 2019, 10, 5064–5072.
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Fig. 24 Overlay of 1H-15N HSQC spectra of selectively 15N leucine labeled hCA II S166C labeled with Tm-DOTA-M8-(4R,4S)-SSPy34 (orange), Tm-P4M4-DOTA
(blue) and Lu-P4M4-DOTA (black) measured at 600 MHz proton frequency (left). Remarkably, due to the low spectral complexity, the PCSs can be readily assigned
and leucine-derived anisotropy parameters can be fitted. Presence of peaks affected in intensity due to the applied water suppression method is demonstrated in an
extra panel (right).36
Fig. 25 Influence of different temperatures on shifts induced by the Dy-DOTA-M8-(8S)-SSPy LCT29 on an ubiquitin S57C construct (structure of the LCT depicted
in part A).70 The major and minor species originate in two conformational isomers (B) that interconvert on a slow timescale (twisted square antiprism (TSAP) and
square antiprism (SAP), see also Section 2.6). The observed temperature dependence of the induced PCS, i.e. the movement of the paramagnetic shift to the
diamagnetic reference peak upon increase of the measuring temperature, can be used in order to unambiguously assign PCSs in a crowded spectral region of a
1H-15N HSQC experiment (C, 288 K: purple, 298 K: blue, 308 K: cyan).70 Strickland, M.; Schwieters, C. D.; Göbl, C.; Opina, A. C. L.; Strub, M.-P.; Swenson, R. E.;
Vasalatiy, O.; Tjandra, N., J. Biomol. NMR 2016, 66, 125–139.
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Fig. 26 Spectral overlay of a selection of peaks in 1H-15N HSQC experiments of Ln-DOTA-M7FPy,35 loaded with various lanthanoid ions, attached to an ubiquitin
S57C construct. The measurement of multiple lanthanoid ions allows to critically assess the PCS assignment in crowded regions of a 1H-15N HSQC spectrum by
comparing the induced patterns of shifts.
Table 1 Anisotropy parameters for the hCA II constructs tagged with Tm-DOTA-M8-(8S)-SSPy.
Parameter Unit S50C Tm-DOTA S166C Tm-DOTA S217C Tm-DOTA S220C Tm-DOTA S166C Tm-Thiazole
No. of PCS – 366 397 364 366 44
△wax [10
−32 m3] 21.6  1.2 38.5  2.0 25.7  1.0 23.6  0.9 34.7  0.6
△wrh [10
−32 m3] 8.5  0.7 8.0  1.0 13.2  0.6 4.3  0.3 13.3  1.1
x [Å] −27.8  0.3 −16.3  0.4 −24.9  0.2 −13.1  0.3 −11.8  0.5
y [Å] 13.7  0.3 −3.6  0.4 −17.7  0.3 −26.7  0.3 −1.7  0.1
z [Å] 18.1  0.3 −11.2  0.4 19.6  0.2 3.2  0.2 −11.0  0.2
a [] 104.1  1.6 52.2  1.8 143.7  0.8 14.9  1.4 119.4  4.4
b [] 142.3  1.1 123.6  1.4 70.9  0.5 153.6  0.6 162.1  0.5
g [] 116.2  1.7 140.3  5.6 125.5  1.0 1.0  2.6 44.8  3.7
Q 0.072 0.037 0.064 0.106 0.061
Monte-Carlo structure variation with s ¼ 0.5 Å. s ¼ 0.05 Å
△wax [10
−32 m3] 21.1  0.9 37.4  0.9 25.5  1.1 23.0  2.1 34.3  0.8
△wrh [10
−32 m3] 8.5  0.6 7.8  0.6 13.1  0.6 4.4  0.8 12.7  1.6
x [Å] −27.5  0.3 −16.2  0.2 −24.8  0.2 −13.0  0.6 −12.0  0.7
y [Å] 13.6  0.2 −3.6  0.2 −17.5  0.3 −26.4  0.6 −1.8  0.2
z [Å] 18.2  0.2 −11.0  0.2 19.6  0.2 3.2  0.5 −10.8  0.4
a [] 104.0  1.8 52.7  1.2 143.3  0.8 16.2  3.5 121.6  6.8
b [] 141.8  0.8 123.1  0.7 71.2  0.7 153.7  1.5 161.6  1.1
g [] 115.9  1.7 141.1  2.7 125.1  1.1 3.9  6.6 45.1  5.2
Q 0.071 0.035 0.068 0.106 0.059
Monte-Carlo protocol where random subsets consisting of 20% of the available PCS were used.
Reproduced by permission of The Royal Society of Chemistry from Zimmermann, K.; Joss, D.; Müntener, T.; Nogueira, E. S.; Schäfer, M.; Knörr, L.; Monnard, F. W.; Häussinger, D.
Chem. Sci. 2019, 10, 5064–5072.
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Fig. 27 One-dimensional 19F NMR spectra of the difluorinated ligand F2-Inh incorporated into hCA II constructs that were labeled at different sites within the
protein. The observed peaks of the ligand incorporated in the different hCA II constructs are significantly broadened when compared with the unbound ligand due to
the higher rotational correlation time. Since the different hCA II constructs labeled with a diamagnetic LCT did not exhibit any differences, a hCA II S220C construct
labeled with Lu-DOTA-M8-(8S)-SSPy was used as reference. The one-dimensional 19F NMR spectra were referenced using an internal signal of trifluoroacetate at
−79.0 ppm. Reproduced by permission of The Royal Society of Chemistry from Zimmermann, K.; Joss, D.; Müntener, T.; Nogueira, E. S.; Schäfer, M.; Knörr, L.;
Monnard, F. W.; Häussinger, D. Chem. Sci. 2019, 10, 5064–5072.











The position of the observed spin characterized by the distance to the metal center r as well as the azimuth (f) and zenith (y) angles
leads then to the calculated PCS by taking into account the axial and rhombic anisotropy (Dwax and Dwrh) parameters.
In order to calculate the position of the fluorine atom(s) of the chosen sulfonamide ligands, the fitted anisotropy tensors based
on the PCS of the amide NdH spin pairs can be used to back-calculate the position of the ligand by taking as input the 19F PCS
measured on the ligand while being complexed with the tagged protein. In order to obtain the position in an unambiguous fashion
by using least-squares fitting, four different anisotropy tensors were used in the study. Furthermore, in order to further enhance the
accuracy, a fifth anisotropy tensor with an additional orthogonal isosurface can be incorporated during the least-squares minimi-
zation. The square residual that is minimized during the process is given by the following definition:
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The definition is composed by the sum of the deviation between the experimentally measured PCS and the back-calculated PCS,
whereas i is the corresponding tensor index and di
PCS(experiment) is the experimental PCS. The back-calculated PCS is given by the
semi-empirical formula of Kurland and McGarvey178 for the PCS in Cartesian coordinates that incorporates the positioning of the
spin (x,y,z), the distance from the spin to the paramagnetic center as well as the anisotropy parameters Dwax,i and Dwrh,i, which give







































The difference between back-calculated andmeasured PCS, i.e. the function s(x,y,z), leads then straightforward to the position of the
fluorine nuclei of the tested ligand. However, one has further to account for the uncertainties of the used anisotropy tensors.
Therefore, a Monte-Carlo protocol was implemented in the algorithm that introduces errors based on a random seed and performs
10,000 iterations in order to have a statistically valid sampling number.179 The introduced uncertainties are based on the errors of
the tensor values determined during the fitting process using Numbat.97
By application of the described protocol in our model system, the tested inhibitors were successfully localized using PCS
restraints with an accuracy of up to 0.8 Å. Furthermore, the inhibitors were localized over a through-space distance of 22–38 Å, a
previously unprecedented distance range. Earlier studies reported localizations of ligands over distances of 10–25 Å,40,102,151 results
Fig. 28 Point cloud obtained in the Monte-Carlo calculation of the position of the fluorine atoms of FM-520 (left) and FM-519 (right). Light blue sticks indicate
fluorine atoms, while the blue sphere represents the zinc(II) ion (modified PDB 1G54).41,177 Reproduced by permission of The Royal Society of Chemistry from
Zimmermann, K.; Joss, D.; Müntener, T.; Nogueira, E. S.; Schäfer, M.; Knörr, L.; Monnard, F. W.; Häussinger, D. Chem. Sci. 2019, 10, 5064–5072.
24 Application of Paramagnetic LCTs in NMR Spectroscopythat were already considered as highly promising given that for NOESY a distance limitation of 5–8 Å applies and a complete
sidechain assignment is required. The key factor for the distance range that was monitored in the present study lies in the use of the
strongly paramagnetic LCTs that lead to large PCS detected for the ligand atoms. With the newest generations of strongly
paramagnetic LCTs available today, distances over 200 Å can be sampled in the optimal case, i.e. given a favorable alignment of
the induced anisotropy with the protein.18 For proteins with a mainly globular fold, the newest generation of LCTs would even
allow to localize ligands in proteins over 500 kDa, which includes most proteins suitable for NMR spectroscopy by today.
The determined position for the ligands FM-519 and FM-520 shows deviations of 3.3 and 0.8 Å when compared to the X-ray
structure of hCA II incorporating a pentafluorobenzyl-substituted ligand (PDB 1G54)177 (Fig. 28). Interestingly, the found
deviations of the position found for the ligand F2-Inh by PCS and in the X-ray structure (PDB 1G52)177 deviate more strongly,
although the intramolecular distance between the two fluorine atoms in ortho- and meta position of the phenyl ring of the ligand is
very accurately reproduced (determined as 3.5 Å compared to 2.8 Å in the X-ray structure (modified PDB 1G52)177). However,
based on our results and MP2 calculations that investigate the interactions of differently fluorinated benzyl rings with another
nonfluorinated benzyl ring (Motif 1b on page 2 of Ref. 180), it was proposed that the outer aromatic ring of the ligand aligns in
solution different from the conformation found in the crystal structure due to the interactions with the neighboring phenyl
substituent of Phe-131. By taking into account the possible structural changes of the outer phenyl ring of the ligand in solution,
the positional deviations coincided within 1.6 Å with the fluorine in meta position of the difluorophenyl substituent and 2.6 Å for
the fluorine in ortho position.4.5 Determination of the Ligand Position by Analysis of the Isosurfaces of the Anisotropy Parameters
In principle, the position of the investigated ligand can very simply be obtained by using only the intersection of three back-
calculated isosurfaces for a specific PCS based on the respective previously determined anisotropy tensors. This approach wins
clearly over the Monte-Carlo method, which incorporates more than three anisotropy tensors, by its pure straightforwardness.
However, by taking in account only three anisotropy tensors, the result could be corroborated due to an unfavorable alignment and
thus not sufficient orthogonality of the used isosurfaces. In order to investigate the described approach and quantify its deviations
and pitfalls, the position was determined for all three applied ligands in the study with all possible combinations of tensor
isosurfaces. The orthogonality of tensors was determined by the intersection angle of the normal vectors at the intersection point.
The obtained results clearly show that the closer the intersection angles match 90 degrees, the more precise the position can be
determined. In order to reflect the found intersection angles and the suitability of a given combination of isosurfaces, an angle score
was defined by calculating the sum of the deviations of the intersection angles to 90 degrees and dividing the result by 3. Therefore,
an angle score of 0 degree states perfect orthogonality of the used isosurfaces, while 90 degrees indicates parallel isosurfaces.
We found that the combination of isosurfaces with an angle score below 30 degrees closely match the positions determined using
the Monte-Carlo protocol (average deviation for combinations of isosurfaces with an angle score below 30 degrees of all four
ligands: 2.3 Å) (Fig. 29). For combinations exhibiting an angle score of over 40 degrees, the deviations amount to 7 Å or more.
Therefore, it can be concluded that the use of only three different isosurfaces can be used to localize the ligand given that the used
isosurfaces show a favorable angle score. Even for combinations of isosurfaces with an unfavorable angle score, the achieved
accuracy would still allow a coarse-grained localization of the ligand and thus enable to discriminate two different, distant binding
sites for the ligands within the investigated protein.4.6 1H-19F-HOESY Experiments for Determination of 1H PCS of the Ligand and Protein–Ligand Interactions
Since it is impossible to discriminate the proton signals of the bound ligand and the protein host present in equimolar ratios within
the sample, 1H-19F heteronuclear Overhauser effect spectroscopy (HOESY) experiments were measured in order to determine the 1H
Fig. 29 Points of intersection of isosurfaces induced by LCTs on different tagging sites (ligand FM-520, center of gravity of the CF3 fluorine atoms: cyan (modified
PDB 1G54),177 fluorine atoms: light blue sticks, position obtained by least square minimization using all four tensors: gold, positions obtained by intersection of three
isosurfaces in all possible combinations with an angle score below 30: orange, positions obtained by intersection of three isosurfaces in all possible combinations
with an angle score above 30: red).41 Reproduced by permission of The Royal Society of Chemistry from Zimmermann, K.; Joss, D.; Müntener, T.; Nogueira, E. S.;
Schäfer, M.; Knörr, L.; Monnard, F. W.; Häussinger, D. Chem. Sci. 2019, 10, 5064–5072.
Fig. 30 HOESY spectra of hCA II constructs incorporating the ligand F2-Inh. The correlation peaks represent through-space interactions of 19F with 1H. Due to the
narrow sweep width, the signals for aliphatic protons appear at their aliased frequency.181 Zimmermann, K.; Joss, D.; Müntener, T.; Nogueira, E. S.; Schäfer, M.;
Knörr, L.; Monnard, F. W.; Häussinger, D., Chem. Sci. 2019, 10, 5064–5072.
Application of Paramagnetic LCTs in NMR Spectroscopy 25PCS of proton atoms of the bound ligand (F2-Inh), which are close in space to the fluorine atoms. The experiments revealed four
correlation peaks with variable intensities (Fig. 30). Due to the small sweep width, the peaks appear at their aliased frequency.
In order to analyze their original NMR shift, spectra with a larger spectral window were recorded. The obtained results show that
three peaks originate from correlation of fluorine with sidechain methyl groups, since their proton frequency was found in the
aliphatic region between 0.4 and 0.75 ppm. The strongest 1H-19F HOESY correlation peak was considered to constitute the cross
peak of the proton in para-position of the fluorinated phenyl ring of the ligand with the fluorine in ortho- and meta position.
26 Application of Paramagnetic LCTs in NMR SpectroscopyUpon determination of the 1H PCS, the aromatic proton atom of F2-Inh in para position was localized within the protein by
fitting of its experimentally determined PCS to the back-calculated PCS based on the anisotropy tensors derived from the HdN
signals. The positional deviation of the proton, based on the PCS approach, amounted to only 1.4 Å when compared with the X-ray
structure of hCA II incorporating the difluorinated ligand F2-Inh (PDB 1G52)177. Interactions of the benzylic fluorine atoms with
side-chain methyl groups are clearly observed and the resonance at 0.41 ppm was, based on its observed PCS, attributed to
interactions with the methyl groups of the residue Val-135.5 Conclusion and Outlook
To conclude, the strongly paramagnetic LCTs that are available today yield accurate restraints for the structural elucidation of
biomacromolecules in solution, i.e. in vitro as well as in cellulo. PCS analysis offers the possibility to investigate the three-
dimensional structure, conformations and dynamics of biomacromolecules. Furthermore, the site of ligand-binding and the
structure of the protein–ligand complex can be resolved by the structural restraints obtained by application of an LCT.
As demonstrated by various research groups, nuclei as 1H, 13C and 19F in combination with different NMR approaches, e.g.
conventional 1H or 19F one-dimensional spectra, 19F CEST and 1H relaxation dispersion, can be applied in order to achieve a
reasonable signal discrimination of the ligand signals from the protein. The chosen approach depends on the measured nucleus as
well as on the affinity of the ligand, i.e. ligands that show weak, intermediate or strong binding. The distance range that can be
covered according to the reported literature (10–38 Å) renders this unique method highly suitable for biologically relevant
applications. This can be achieved by the application of covalently binding and strongly paramagnetic LCTs to the protein that
generate large PCSs and provide therefore accurate structural restraints for the measured nuclei.
By use of human carbonic anhydrase II and incorporated sulfonamide ligands, which interact with nM to pM Kd-values with the
zinc metal center, it was shown that it is possible to unambiguously localize a ligand bound 19F atom within a protein approaching
an accuracy of 0.8 Å. Solely based on the fluorine PCS caused by LCTs over a distance of 22–38 Å by measuring 4–5 one-
dimensional 19F spectra per ligand, one unique solution for the position of the fluorine atoms was obtained. Besides Monte-
Carlo calculations with 4 or 5 different anisotropy tensors, graphical analysis using only three isosurfaces shows a high accuracy as
long as sufficient orthogonality of the isosurfaces is confirmed by application of an angle score. When only combinations are taken
into account showing an angle score below 30 degrees, the obtained accuracy allows a clear localization of the fluorine atom and the
position matches the one determined in Monte-Carlo protocols using four tensors. By omitting the need for solvent suppression,
chemical modification of the ligand and extensive measurement times during the screening process, the method constitutes a fast,
reliable and convenient approach to screen a high number of fluorine-containing ligands for a specific protein.
The use of LCTs for the characterization of protein–ligand complexes in solution can deliver accurate structural restraints over a
large distance and thus holds great promise for future applications in structural biology and rational drug design. With the newest
generation of LCTs in hand, the localization of ligands by PCS can further be extended to proteins with molecular weights
significantly larger than 30 kDa and large, multimeric protein complexes.Acknowledgment
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